TY  - GEN
AU  - Wu,Xue-Feng
AU  - Xu,Rui
AU  - Ouyang,Zi-Jun
AU  - Qian,Cheng
AU  - Shen,Yan
AU  - Wu,Xu-Dong
AU  - Gu,Yan-Hong
AU  - Xu,Qiang
AU  - Sun,Yang
TI  - Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway
SN  - 1932-6203
PY  - 2014///0930
KW  - Animals
KW  - Apoptosis
KW  - Cell Proliferation
KW  - drug effects
KW  - Colitis
KW  - chemically induced
KW  - Depsipeptides
KW  - therapeutic use
KW  - Disease Models, Animal
KW  - Down-Regulation
KW  - Female
KW  - Flow Cytometry
KW  - Gene Expression Regulation, Enzymologic
KW  - Inflammation
KW  - Interferon-gamma
KW  - metabolism
KW  - Lymphocyte Activation
KW  - Membrane Potential, Mitochondrial
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Phosphatidylinositol 3-Kinases
KW  - Phosphorylation
KW  - Proto-Oncogene Proteins c-akt
KW  - Signal Transduction
KW  - T-Lymphocytes
KW  - Trinitrobenzenesulfonic Acid
KW  - chemistry
KW  - Tumor Necrosis Factor-alpha
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0083013
ER  -